Brian Park, PharmD

Drug Information Specialist https://www.thecardiologyadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Vascular Medicine

FDA to Review Avacopan for ANCA-Associated Vasculitis

Brian Park, PharmD

September 28, 2020

Avacopan is an orally-administered, small molecule designed to selectively block the complement 5a receptor on destructive inflammatory cells such as blood neutrophils.

Dyslipidemia

Consistent LDL-C Lowering Reported With Twice-Yearly Inclisiran

Brian Park, PharmD

September 14, 2020

The post-hoc analysis included 2 placebo-controlled phase 3 studies (ORION-10 and -11) that evaluated the efficacy and safety of inclisiran sodium in more than 2300 adult patients.

Vascular Medicine

Coronary Plaque Regression Observed With Icosapent Ethyl

Brian Park, PharmD

September 9, 2020

The phase 4 EVAPORATE study assessed the effects of icosapent ethyl on the progression of coronary atherosclerosis in 80 adult patients with elevated triglycerides.

Dyslipidemia

Evolocumab Lowers LDL-C in Pediatric Patients With HeFH

Brian Park, PharmD

September 4, 2020

The multicenter, double-blind, placebo-controlled HAUSER-RCT study assessed the efficacy and safety of evolocumab in 157 patients aged 10 to 17 years with HeFH.

General Cardiology

Abbott’s 15-Minute COVID-19 Antigen Test Gets Emergency Use Authorization

Brian Park, PharmD

September 2, 2020

Results are provided within 15 minutes and can be read directly from the testing card.

Hypertension, News

FDA: Small Risk of Skin Cancer With Hydrochlorothiazide Use

Brian Park, PharmD

August 27, 2020

Hydrochlorothiazide is indicated for the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives.